Postapproval Comparative Safety Study of Tofacitinib and Biological Disease‐Modifying Antirheumatic Drugs: 5‐Year Results from a United States–Based Rheumatoid Arthritis Registry - Kremer, Joel M.; Bingham, Clifton O.; Cappelli, Laura C.; Greenberg, Jeffrey D.; Madsen, Ann M.; Geier, Jamie; Rivas, Jose L.; Onofrei, Alina M.; Barr, Christine J.; Pappas, Dimitrios A.; Litman, Heather J.; Dandreo, Kimberly J.; et al. (ACR open rheumatology, 2021)
Keywords: Clinical trials; Comparative analysis; Data collection; Drug dosages; FDA approval; Original; Patients; Prescription drugs; Rheumatoid arthritis; United States--US